QR Code

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD), ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), is a liver disease worldwide without approved therapeutic drugs. Anti-inflammatory and hepatoprotective drug bicyclol and multi-pharmacological active drug berberine, respectively, have sh...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Hu Li, Nan-Nan Liu, Jian-Rui Li, Biao Dong, Mei-Xi Wang, Jia-Li Tan, Xue-Kai Wang, Jing Jiang, Lei Lei, Hong-Ying Li, Han Sun, Jian-Dong Jiang, Zong-Gen Peng
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Frontiers Media S.A. 2022-02-01
Rangatū:Frontiers in Pharmacology
Ngā marau:
nonalcoholic fatty liver disease
bicyclol
berberine
combination
lipid metabolism
gut microbiota
Urunga tuihono:https://www.frontiersin.org/articles/10.3389/fphar.2022.843872/full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite